Literature DB >> 19855164

Interactions between DBC1 and SIRT 1 are deregulated in breast cancer cells.

Ja-Eun Kim, Zhenkun Lou, Junjie Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19855164     DOI： 10.4161/cc.8.22.10055

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  19 in total

1.  A biotin switch-based proteomics approach identifies 14-3-3ζ as a target of Sirt1 in the metabolic regulation of caspase-2.

Authors:  Joshua L Andersen; J Will Thompson; Kelly R Lindblom; Erika S Johnson; Chih-Sheng Yang; Lauren R Lilley; Christopher D Freel; M Arthur Moseley; Sally Kornbluth
Journal:  Mol Cell       Date:  2011-09-02       Impact factor: 17.970

Review 2.  Circadian rhythm disruption in cancer biology.

Authors:  Christos Savvidis; Michael Koutsilieris
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

3.  MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.

Authors:  Ruth L Vinall; Alexandra Z Ripoll; Sisi Wang; Chong-Xian Pan; Ralph W deVere White
Journal:  Int J Cancer       Date:  2011-12-02       Impact factor: 7.396

4.  The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target.

Authors:  Lydia Brandl; Nina Kirstein; Jens Neumann; Andrea Sendelhofert; Michael Vieth; Thomas Kirchner; Antje Menssen
Journal:  Med Oncol       Date:  2018-11-20       Impact factor: 3.064

5.  DBC1 does not function as a negative regulator of SIRT1 in liver cancer.

Authors:  Hyun Jin Bae; Young Gyoon Chang; Ji Heon Noh; Jeong Kyu Kim; Jung Woo Eun; Kwang Hwa Jung; Min Gyu Kim; Qingyu Shen; Young Min Ahn; So Hee Kwon; Won Sang Park; Jung Young Lee; Suk Woo Nam
Journal:  Oncol Lett       Date:  2012-08-23       Impact factor: 2.967

6.  Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions.

Authors:  Li Qiang; Ning Kon; Wenhui Zhao; Le Jiang; Colette M Knight; Carrie Welch; Utpal Pajvani; Wei Gu; Domenico Accili
Journal:  Cell Rep       Date:  2015-06-11       Impact factor: 9.423

7.  The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.

Authors:  Antje Menssen; Per Hydbring; Karsten Kapelle; Jörg Vervoorts; Joachim Diebold; Bernhard Lüscher; Lars-Gunnar Larsson; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-21       Impact factor: 11.205

8.  Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism.

Authors:  Basil P Hubbard; Christine Loh; Ana P Gomes; Jun Li; Quinn Lu; Taylor Lg Doyle; Jeremy S Disch; Sean M Armour; James L Ellis; George P Vlasuk; David A Sinclair
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

9.  A Functional Proteomics Perspective of DBC1 as a Regulator of Transcription.

Authors:  P Joshi; O L Quach; S S B Giguere; I M Cristea
Journal:  J Proteomics Bioinform       Date:  2013-04-18

10.  Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary.

Authors:  Yoshihiro Morita; Osamu Wada-Hiraike; Tetsu Yano; Akira Shirane; Mana Hirano; Haruko Hiraike; Satoshi Koyama; Hajime Oishi; Osamu Yoshino; Yuichiro Miyamoto; Kenbun Sone; Katsutoshi Oda; Shunsuke Nakagawa; Kazuyoshi Tsutsui; Yuji Taketani
Journal:  Reprod Biol Endocrinol       Date:  2012-02-23       Impact factor: 5.211
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.